Viewing Study NCT00519259


Ignite Creation Date: 2025-12-24 @ 2:31 PM
Ignite Modification Date: 2026-01-07 @ 5:39 AM
Study NCT ID: NCT00519259
Status: UNKNOWN
Last Update Posted: 2017-01-11
First Post: 2006-06-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1
Sponsor: National Institute on Drug Abuse (NIDA)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module